[Current tendency in treatment for acute ischemic stroke].
Katayama
Y
Y
Second Department of Internal Medicine, Nippon Medical School.
D000208:Acute Disease; D000818:Animals; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D016166:Free Radical Scavengers / Q000627:therapeutic use; D005990:Glycerol / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016559:Tacrolimus / Q000008:administration & dosage; D013997:Time Factors
D005343:Fibrinolytic Agents; D016166:Free Radical Scavengers; D007166:Immunosuppressive Agents; D005990:Glycerol; D016559:Tacrolimus